Truxton Trust Announces Changes to Executive Leadership
NASHVILLE, Tenn., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Truxton Trust Company announced today executive leadership changes
Globe Newswire3-02-2023, 00:24
Boehringer’s zongertinib receives Priority Review from U.S. FDA for the treatment of HER2 (ERBB2)-mutant advanced non-small cell lung cancer 19-02-2025, 19:05